Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jenny Sprooten

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Cancers|December 24, 2021
Identification of Potential Prognostic and Predictive Immunological Biomarkers in Patients with Stage I and Stage III Non-Small Cell Lung Cancer (NSCLC): A Prospective Exploratory StudyRianne D W Vaes, Kobe Reynders, Jenny Sprooten, et al.
Oncoimmunology|October 14, 2024
Trial watch: anticancer vaccination with dendritic cellsFrancisca Borges, Raquel S Laureano, Isaure Vanmeerbeek, et al.
Science Advances|July 19, 2024
Targeting conserved TIM3<sup>+</sup>VISTA<sup>+</sup> tumor-associated macrophages overcomes resistance to cancer immunotherapyIsaure Vanmeerbeek, Stefan Naulaerts, Jenny Sprooten, et al.
Journal for Immunotherapy of Cancer|November 19, 2021
Peripherally-driven myeloid NFkB and IFN/ISG responses predict malignancy risk, survival, and immunotherapy regime in ovarian cancerJenny Sprooten, Ann Vankerckhoven, Isaure Vanmeerbeek, et al.
Nature Medicine|May 21, 2024
A spatial architecture-embedding HLA signature to predict clinical response to immunotherapy in renal cell carcinomaLisa Kinget, Stefan Naulaerts, Jannes Govaerts, et al.
Cell Discovery|November 15, 2023
Single cell dynamics of tumor specificity vs bystander activity in CD8<sup>+</sup> T cells define the diverse immune landscapes in colorectal cancerDaniel Morales Borràs, Sara Verbandt, Markus Ausserhofer, et al.
Cell Reports. Medicine|January 17, 2024
Lymph node and tumor-associated PD-L1<sup>+</sup> macrophages antagonize dendritic cell vaccines by suppressing CD8<sup>+</sup> T cellsJenny Sprooten, Isaure Vanmeerbeek, Angeliki Datsi, et al.
Oncoimmunology|July 8, 2022
Trial watch: Dendritic cell (DC)-based immunotherapy for cancerRaquel S Laureano, Jenny Sprooten, Isaure Vanmeerbeerk, et al.
Oncoimmunology|June 7, 2023
Trial watch: chemotherapy-induced immunogenic cell death in oncologyJenny Sprooten, Raquel S Laureano, Isaure Vanmeerbeek, et al.
Science Translational Medicine|April 12, 2023
Multiomics and spatial mapping characterizes human CD8<sup>+</sup> T cell states in cancerStefan Naulaerts, Angeliki Datsi, Daniel M Borras, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Cancers|December 24, 2021
Identification of Potential Prognostic and Predictive Immunological Biomarkers in Patients with Stage I and Stage III Non-Small Cell Lung Cancer (NSCLC): A Prospective Exploratory StudyRianne D W Vaes, Kobe Reynders, Jenny Sprooten, et al.
Oncoimmunology|October 14, 2024
Trial watch: anticancer vaccination with dendritic cellsFrancisca Borges, Raquel S Laureano, Isaure Vanmeerbeek, et al.
Science Advances|July 19, 2024
Targeting conserved TIM3<sup>+</sup>VISTA<sup>+</sup> tumor-associated macrophages overcomes resistance to cancer immunotherapyIsaure Vanmeerbeek, Stefan Naulaerts, Jenny Sprooten, et al.
Journal for Immunotherapy of Cancer|November 19, 2021
Peripherally-driven myeloid NFkB and IFN/ISG responses predict malignancy risk, survival, and immunotherapy regime in ovarian cancerJenny Sprooten, Ann Vankerckhoven, Isaure Vanmeerbeek, et al.
Nature Medicine|May 21, 2024
A spatial architecture-embedding HLA signature to predict clinical response to immunotherapy in renal cell carcinomaLisa Kinget, Stefan Naulaerts, Jannes Govaerts, et al.
Cell Discovery|November 15, 2023
Single cell dynamics of tumor specificity vs bystander activity in CD8<sup>+</sup> T cells define the diverse immune landscapes in colorectal cancerDaniel Morales Borràs, Sara Verbandt, Markus Ausserhofer, et al.
Cell Reports. Medicine|January 17, 2024
Lymph node and tumor-associated PD-L1<sup>+</sup> macrophages antagonize dendritic cell vaccines by suppressing CD8<sup>+</sup> T cellsJenny Sprooten, Isaure Vanmeerbeek, Angeliki Datsi, et al.
Oncoimmunology|July 8, 2022
Trial watch: Dendritic cell (DC)-based immunotherapy for cancerRaquel S Laureano, Jenny Sprooten, Isaure Vanmeerbeerk, et al.
Oncoimmunology|June 7, 2023
Trial watch: chemotherapy-induced immunogenic cell death in oncologyJenny Sprooten, Raquel S Laureano, Isaure Vanmeerbeek, et al.
Science Translational Medicine|April 12, 2023
Multiomics and spatial mapping characterizes human CD8<sup>+</sup> T cell states in cancerStefan Naulaerts, Angeliki Datsi, Daniel M Borras, et al.
Pageof 2